Medications
Myrbetriq approved for overactive bladder
(HealthDay) -- Myrbetriq (mirabegron) has been approved to treat adults with overactive bladder, a condition affecting some 33 million Americans, the U.S. Food and Drug Administration said Thursday in a news release.
Jun 28, 2012
0
0
